España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bayer
BAYRY
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.36
0.06
1.13%
At close: -
Get Report
Comment
Bayer (BAYRY) Forecast
News
Earnings
Bayer (BAYRY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Bayer (OTC:BAYRY) Stock
Bayer Stock (OTC: BAYRY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
Vandana Singh
Cytokinetics And Bayer Partner For Exclusive ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Bayer Confirms Its 2024 Guidance, Sales Of €4...
Benzinga Newsdesk
Bayer Q3 2024 Adj. EPADS $0.07 Misses $0.17 E...
Benzinga Newsdesk
Tuesday, October 15, 2024
Bayer Seeks European Approval For Its Menopause Drug
Vandana Singh
Monday, October 14, 2024
Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide
Vandana Singh
Tuesday, September 24, 2024
Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time
Zacks
Monday, September 16, 2024
Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
Vandana Singh
Tuesday, September 10, 2024
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
Vandana Singh
Friday, August 30, 2024
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
Vandana Singh
Tuesday, August 27, 2024
Regeneron's Bispecific Antibody Obtains EC Nod for Lymphoma
Zacks
Thursday, August 01, 2024
Regeneron Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
Zacks
Thursday, July 25, 2024
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Vandana Singh
Wednesday, June 05, 2024
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Vandana Singh
Monday, May 27, 2024
European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
Piero Cingari
Friday, May 24, 2024
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Vandana Singh
Friday, May 17, 2024
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Vandana Singh
Thursday, May 16, 2024
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Upwallstreet
Friday, May 10, 2024
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
Vandana Singh
Thursday, May 02, 2024
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Vandana Singh
Wednesday, April 10, 2024
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
Avi Kapoor
Tuesday, April 09, 2024
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
Vandana Singh
Friday, April 05, 2024
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Piero Cingari
Tuesday, March 19, 2024
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Vandana Singh
Thursday, March 14, 2024
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Vandana Singh
Wednesday, March 06, 2024
Boundless Bio Files For IPO; Applies To List ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Vandana Singh
Monday, March 04, 2024
What's Going On With BridgeBio Pharma Stock On Monday?
Vandana Singh
BridgeBio Pharma And Bayer Announce European ...
Benzinga Newsdesk
Tuesday, January 30, 2024
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Vandana Singh
Monday, January 29, 2024
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Vandana Singh
Thursday, January 11, 2024
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Vandana Singh
Monday, January 08, 2024
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Vandana Singh
Thursday, January 04, 2024
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Vandana Singh
Wednesday, January 03, 2024
Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024
Chris Katje
Tuesday, December 26, 2023
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Vandana Singh
Tuesday, December 19, 2023
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Surbhi Jain
Wednesday, December 06, 2023
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Vandana Singh
Monday, December 04, 2023
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Vandana Singh
Tuesday, November 28, 2023
PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out
Natan Ponieman
Friday, November 24, 2023
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Vandana Singh
Monday, November 20, 2023
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Vandana Singh
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Vandana Singh
Friday, November 17, 2023
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Vandana Singh
Tuesday, November 14, 2023
AI Is Pharma's Newest Power Tool For Enhancing Clinical Trials
Upwallstreet
Thursday, November 09, 2023
Bayer And Recursion Focus Research Collaborat...
Benzinga Newsdesk
Wednesday, November 08, 2023
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
Vandana Singh
Wednesday, November 01, 2023
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
Vandana Singh
Friday, October 13, 2023
Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles
The Bamboo Works
Friday, September 22, 2023
AI To Revolutionize Clinical Trials And Diagnostics
Upwallstreet
Show More
